Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,821 to 1,840 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mono (2-ethylhexyl) phthalate (MEHP) triggers the proliferation of hemangioma-derived endothelial cells via YAP signals. | Chem Biol Interact | 2019 | 31351048 | PubTator, text mining | PubMed |
| In Vivo Study on the Effects of Xiaoaiping on the Stemness of Hepatocellular Carcinoma Cells. | Evid Based Complement Alternat Med | 2019 | 31341493 | PubTator, text mining | PubMed |
| Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. | Nature | 2019 | 31341276 | PubTator, text mining | PubMed |
| The molecular genetic make-up of male breast cancer. | Endocr Relat Cancer | 2019 | 31340200 | PubTator, text mining | PubMed |
| YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway. | Cancer Cell Int | 2019 | 31337986 | PubTator, text mining | PubMed |
| RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation. | Oncogene | 2019 | 31332287 | PubTator, text mining | PubMed |
| β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer. | Nat Commun | 2019 | 31324767 | PubTator, text mining | PubMed |
| LATS1/2 suppress NFκB and aberrant EMT initiation to permit pancreatic progenitor differentiation. | PLoS Biol | 2019 | 31323030 | PubTator, text mining | PubMed |
| Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus. | PLoS Biol | 2019 | 31323018 | PubTator, text mining | PubMed |
| miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway. | Oxid Med Cell Longev | 2019 | 31316723 | PubTator, text mining | PubMed |
| High-throughput sequencing analysis of the expression profile of microRNAs and target genes in mechanical force-induced osteoblastic/cementoblastic differentiation of human periodontal ligament cells. | Am J Transl Res | 2019 | 31312353 | PubTator, text mining | PubMed |
| SNHG15: a promising cancer-related long noncoding RNA. | Cancer Manag Res | 2019 | 31308739 | PubTator, text mining | PubMed |
| Super-Enhancer-Associated LncRNA UCA1 Interacts Directly with AMOT to Activate YAP Target Genes in Epithelial Ovarian Cancer. | iScience | 2019 | 31307004 | PubTator, text mining | PubMed |
| Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer. | Mol Ther Nucleic Acids | 2019 | 31302495 | PubTator, text mining | PubMed |
| Src-mediated crosstalk between FXR and YAP protects against renal fibrosis. | FASEB J | 2019 | 31298930 | PubTator, text mining | PubMed |
| Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. | Nat Commun | 2019 | 31296870 | PubTator, text mining | PubMed |
| SOX9 promotes epithelial-mesenchymal transition via the Hippo-YAP signaling pathway in gastric carcinoma cells. | Oncol Lett | 2019 | 31289532 | PubTator, text mining | PubMed |
| O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability. | Theranostics | 2019 | 31281487 | PubTator, text mining | PubMed |
| G0/G1 Switch 2 Induces Cell Survival and Metastasis through Integrin-Mediated Signal Transduction in Human Invasive Breast Cancer Cells. | Biomol Ther (Seoul) | 2019 | 31272137 | PubTator, text mining | PubMed |
| RASSF1A controls tissue stiffness and cancer stem-like cells in lung adenocarcinoma. | EMBO J | 2019 | 31268606 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=92